Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan
Clinical trial NCT01876368 · COMPLETED
Trial details
- NCT number
- NCT01876368
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.